维普期刊资源整合服务平台（V6.5）

53篇 您的检索式：作者名="TAAL W"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Renoprotective benefits of RAS inhibition : from ACEI to angiotens in II antagonists 显示文摘	TAAL M W BRENNER B M	2000	Kidney Int2000，57，5：	1
2	Preventing catheter related infections in haemodialysis patients显示文摘	TAAL M W FLUCK R J MCLNTYRE C W	2006	Curr Opin Nephrol Hypertens2006，15，6：	1
3	T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication显示文摘	Hongxiang Liu Hongtao Ye Agnes Ruskone-Fourmestraux Daphne De Jong Stefano Pileri Christian Thiede Anne Lavergne Henk Boot Giancarlo Caletti Thomas Wündisch Thierry Molina Babs G. Taal Sabattini Elena Togliani Thomas Pier Luigi Zinzani Andreas Neubauer Ma	2002	Gastroenterology2002，，5：	1
4	Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney显示文摘	Taal M W Zandi-Nejad K Weening B	2000	J Kidney Int2000，58，4：	1
5	Clinical features,mechanisms,and management of pseudoprogression in malignant gliomas显示文摘	Brandsma D Stalpers L Taal W	2008	Lancet Oncol2008，9，5：	1
6	Pathogenesis of diabetic nephropathy:focus on transforming growth factor beta and connective tissue growth factor显示文摘	Taal M W Brenner BM	2001	Curr Opin Nephrol Hypertens2001，10，6：	1
7	Renoprotective benefits of RAS inhibition:from ACEI to angiotcnsin Ⅱ antagonists显示文摘	Taal M W Brenner B M		0，，：	1
8	Inci- dence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozo- lomide 显示文摘	TAAL W BRANDSMA D BRUIN H G	2008	Cancer2008，113，2：	1
9	Renoprotective benefits of RAS inhibition:from ACEI to angiotensin II antagonists显示文摘	TAAL M W BRENNER B M	2000	Kidnety Int2000，57，10：	1
10	The incidence of pseudoprogression in a cohort of malignant glioma patients treated with chemoradiation with temozolomide 显示文摘	Taal W Brandsma D de Bruin H G	2007	Proc Am Soc Clin Oncol2007，25，18：	1
11	Total hip hone mass predicts survival in chronic hemodialysis patients 显示文摘	Taal M W Roe S Masud T	2003	Kidney Int2003，63，3：	1
12	Renoprotective benefits of RAS inhibition:from ACEI to angiotensin Ⅱ antagonists 显示文摘	Taal M W Brenner B M	2000	Kidney Int2000，57，5：	1
13	T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication显示文摘	Hongxiang Liu Hongtao Ye Agnes Ruskone-Fourmestraux Daphne De Jong Stefano Pileri Christian Thiede Anne Lavergne Henk Boot Giancarlo Caletti Thomas Wündisch Thierry Molina Babs G. Taal Sabattini Elena Togliani Thomas Pier Luigi Zinzani Andreas Neubauer Ma	2002	Gastroenterology2002，，：	1
14	Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas 显示文摘	BRANDSMA D STALPERS L TAAL W	2008	Lancet Oncol2008，9，5：	1
15	Renoprotective benefits of RAS inhibition: from ACEI to angiotensin Ⅱ antagonists显示文摘	TAAL M W BRENNER B M	2000	Kidney Int2000，57，：	1
16	First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy:molecular characteristics in relation to response显示文摘	Taal W Dubbink HJ Zonnenberg CB	2011	Neuro Oncol2011，13，2：	1
17	Renoprotective benefits of RAS inhibition: from ACEI to angiotensin I] antagonists显示文摘	Taal M W Brennerl B M	2000	Kidney Int2000，57，5：	1
18	Clinical features, mechanisms and management of pseudoprogression in malignant gliomas 显示文摘	Brandsma D Stalpers L Taal W	2008	Lancet Oncol2008，9，5：	1
19	Renoprotective benefits of RAS inhibition: from ACEI to angiotensi Ⅱ antagonists 显示文摘	Maarten W Taal BM Brenner	2000	Kidney Intemati onal2000，57，：	1
20	Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas显示文摘	grandsma D Stalpers L Taal W	2008	Lancet Oncol2008，9，45：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示